In cancer immunity, STAT3 activation in tumor-associated immune cells promotes the production of immunosuppressive cytokines, including interleukin (IL)-6 and IL-10, while suppressing antitumor cytokines like IL-12 30. Here, IL10 is linked to neoplasm.